Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: A review

Obstetrical and Gynecological Survey

Volumn 65, Issue 7, 2010, Pages 462-473

  Donders, Gilbert ^a,b,c  

^a Regional hospital H Hart Tienen   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFADROXIL; CLINDAMYCIN; ERYTHROMYCIN; ESTRIOL; METRONIDAZOLE; OFLOXACILLIN; ORNIDAZOLE; PLACEBO; PROBIOTIC AGENT; SECNIDAZOLE; TINIDAZOLE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; HEARTBURN; HUMAN; INFECTION PREVENTION; NAUSEA; PAPANICOLAOU TEST; PREGNANCY COMPLICATION; PREVALENCE; PSEUDOMEMBRANOUS COLITIS; RECURRENT DISEASE; REVIEW; SIDE EFFECT; STOMACH PAIN; TERATOGENICITY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VAGINA DISCHARGE; VAGINA FLORA; VAGINA SMEAR; VAGINITIS;

ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SEXUAL BEHAVIOR; TREATMENT OUTCOME; VAGINOSIS, BACTERIAL;

EID: 77956192474     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181e09621     Document Type: Review

References (167)

1. Marrazzo JM, Antonio M, Agnew K, et al. Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis 2009;199:680-683.
2. Akinbiyi AA, Watson R, Feyi-Waboso P. Prevalence of Candida albicans and bacterial vaginosis in asymptomatic pregnant women in South Yorkshire, United Kingdom. Outcome of a prospective study. Arch Gynecol Obstet 2008;278:463-466.
3. Oliveira FA, Pfleger V, Lang K, et al. Sexually transmitted infections, bacterial vaginosis, and candidiasis in women of reproductive age in rural Northeast Brazil: a population-based study. Mem Inst Oswaldo Cruz 2007;102:751-756.
4. Fang X, Zhou Y, Yang Y, et al. Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis for married women of child-bearing age in rural Shandong. Jpn J Infect Dis 2007;60:257-261.
5. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007;34:864-869.
6. Bhalla P, Chawla R, Garg S, et al. Prevalence of bacterial vaginosis among women in Delhi, India. Indian J Med Res 2007;125:167-172.
7. Dan M, Kaneti N, Levin D, et al. Vaginitis in a gynecologic practice in Israel: causes and risk factors. Isr Med Assoc J 2003;5:629-632.
8. Lamont RF, Morgan DJ, Wilden SD, et al. Prevalence of bacterial vaginosis in women attending one of three general practices for routine cervical cytology. Int J STD AIDS 2000; 11:495-498.
9. Schneider H, Coetzee DJ, Fehler HG, et al. Screening for sexually transmitted diseases in rural South African women. Sex Transm Infect 1998;74(suppl 1):S147-S152.
10. Larsson PG, Platz-Christensen JJ, Forsum U, et al. Clue cells in predicting infections after abdominal hysterectomy. Ob-stet Gynecol 1991;77:450-452.
11. Persson E, Bergstrom M, Larsson PG, et al. Infections after hysterectomy. A prospective nation-wide Swedish study. The Study Group on Infectious Diseases in Obstetrics and Gynecology within the Swedish Society of Obstetrics and Gynecology. Acta Obstet Gynecol Scand 1996;75:757-761.
12. Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and Trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990;163: 1016-1021.
13. Charonis G, Larsson PG. Use of pH/whiff test or QuickVue Advanced pH and Amines test for the diagnosis of bacterial vaginosis and prevention of postabortion pelvic inflammatory disease. Acta Obstet Gynecol Scand 2006;85:837-843.
14. Lassey AT, Adanu KR, Newman MJ, et al. Potential pathogens in the lower genital tract at manual vacuum aspiration for incomplete abortion in Korle Bu Teaching Hospital, Ghana. East Afr Med J 2004;81:398-401.
15. Miller L, Thomas K, Hughes JP, et al. Randomised treatment trial of bacterial vaginosis to prevent post-abortion complication. BJOG 2004;111:982-988.
16. Larsson PG, Platz-Christensen JJ, Dalaker K, et al. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study. Acta Obstet Gynecol Scand 2000;79:390-396.
17. Larsson PG, Platz-Christensen JJ, Thejls H, et al. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. Am J Ob-stet Gynecol 1992;166(1 Pt 1):100-103.
18. Chohan VH, Baeten J, Benki S, et al. A prospective study of risk factors for Herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya. Sex Transm Infect 2009;85:348-353.
19. Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008;22:1493-1501.
20. van de Wijgert JH, Morrison CS, Cornelisse PG, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr 2008;48:203-210.
21. Gallo MF, Warner L, Macaluso M, et al. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis 2008;35:679-685.
22. Peipert JF, Lapane KL, Allsworth JE, et al. Bacterial vagino-sis, race, and sexually transmitted infections: does race modify the association? Sex Transm Dis 2008;35:363-367.
23. Kaul R, Nagelkerke NJ, Kimani J, et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007;196:1692-1697.
24. Brotman RM, Erbelding EJ, Jamshidi RM, et al. Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics. J Pediatr Adolesc Gynecol 2007;20:225-231.
25. Nagot N, Ouedraogo A, Defer MC, et al. Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex Transm Infect 2007;83:365-368.
26. Schwebke JR. Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases. J Infect Dis 2005;192:1315-1317.
27. Oakeshott P, Hay P, Hay S, et al. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study. BMJ 2002;325:1334.
28. Donders GG, Van BB, Caudron J, et al. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol 2000;183:431-437.
29. Bacterial vaginosis increases the risk of first trimester miscarriage. BMJ 1999;319.
30. Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ 1999;319:220-223.
31. Hay PE, Lamont RF, Taylor-Robinson D, et al. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308:295-298.
32. Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 2009;116:1315-1324.
33. Thorp JM Jr, Dole N, Herring AH, et al. Alteration in vaginal microflora, douching prior to pregnancy, and preterm birth. Paediatr Perinat Epidemiol 2008;22:530-537.
34. Xu J, Holzman CB, Arvidson CG, et al. Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery. Obstet Gynecol 2008;112:524-531.
35. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007;21:375-390.
36. Guaschino S, De SF, Piccoli M, et al. Aetiology of preterm labour: bacterial vaginosis. BJOG 2006;113(suppl 3):46-51.
37. Svare JA, Schmidt H, Hansen BB, et al. Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG 2006;113:1419-1425.
38. Vogel I, Thorsen P, Hogan VK, et al. The joint effect of vaginal Ureaplasma urealyticum and Bacterial vaginosis on adverse pregnancy outcomes. Acta Obstet Gynecol Scand 2006;85: 778-785.
39. Guerra B, Ghi T, Quarta S, et al. Pregnancy outcome after early detection of bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 2006;128:40-45.
40. Goyal R, Sharma P, Kaur I, et al. Bacterial vaginosis and vaginal anaerobes in preterm labour. J Indian Med Assoc 2004;102:548-550, 553.
41. Romero R, Chaiworapongsa T, Kuivaniemi H, et al. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004;190:1509-1519.
42. Leitich H, Bodner-Adler B, Brunbauer M, et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003;189:139-147.
43. Jacobsson B, Pernevi P, Chidekel L, et al. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet Gynecol Scand 2002; 81:1006-1010.
44. Purwar M, Ughade S, Bhagat B, et al. Bacterial vaginosis in early pregnancy and adverse pregnancy outcome. J Obstet Gynaecol Res 2001;27:175-181.
45. McDonald HM, O'Loughlin JA, Jolley PT, et al. Changes in vaginal flora during pregnancy and association with preterm birth. J Infect Dis 1994;170:724-728.
46. Gravett MG, Hummel D, Eschenbach DA, et al. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986;67:229-237.
47. Landers DV, Wiesenfeld HC, Heine RP, et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004;190:1004-1010.
48. Platz-Christensen JJ, Larsson PG, Sundstrom E, et al. Detection of bacterial vaginosis in wet mount, Papanicolaou stained vaginal smears and in gram stained smears. Acta Obstet Gynecol Scand 1995;74:67-70.
49. Thomason JL, Gelbart SM, Anderson RJ, et al. Statistical evaluation of diagnostic criteria for bacterial vaginosis. Am J Obstet Gynecol 1990;162:155-160.
50. Forsum U, Jakobsson T, Larsson PG, et al. An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis. APMIS 2002; 110:811-818.
51. Donders GG, Larsson PG, Platz-Christensen JJ, et al. Variability in diagnosis of clue cells, lactobacillary grading and white blood cells in vaginal wet smears with conventional bright light and phase contrast microscopy. Eur J Obstet Gynecol Reprod Biol 2009;145:109-112.
52. Donders GG, Van CK, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 2009;116:1315-1324.
53. Donders GG. Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 2007;21:355-373.
54. Donders GG, Vereecken A, Dekeersmaecker A, et al. Wet mount microscopy reflects functional vaginal lactobacillary flora better than Gram stain. J Clin Pathol 2000;53:308-313.
55. Donders GG, Desmyter J, Vereecken A. Vaginitis. N Engl J Med 1998;338:1548.
56. Donders GG, Vereecken A, Bosmans E, et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 2002;109:34-43.
57. Larsson PG, Platz-Christensen JJ. Enumeration of clue cells in rehydrated air-dried vaginal wet smears for the diagnosis of bacterial vaginosis. Obstet Gynecol 1990;76:727-730.
58. Donders GG. Bacterial vaginosis during pregnancy: screen and treat? Eur J Obstet Gynecol Reprod Biol 1999;83:1-4.
59. Hillier SL, Krohn MA, Nugent RP, et al; Vaginal Infections and Prematurity Study Group. Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Am J Obstet Gynecol 1992;166:938-944.
60. Platz-Christensen JJ, Larsson PG, Sundstrom E, et al. Detection of bacterial vaginosis in Papanicolaou smears. Am J Obstet Gynecol 1989;160:132-133.
61. Discacciati MG, Simoes JA, Amaral RG, et al. Presence of 20% or more clue cells: an accurate criterion for the diagnosis of bacterial vaginosis in Papanicolaou cervical smears. Diagn Cytopathol 2006;34:272-276.
62. Eriksson K, Forsum U, Bjornerem A, et al. Validation of the use of Pap-stained vaginal smears for diagnosis of bacterial vaginosis. APMIS 2007;115:809-813.
63. Karani A, De VH, Luchters S, et al. The Pap smear for detection of bacterial vaginosis. Int J Gynaecol Obstet 2007; 98:20-23.
64. Greene JF III, Kuehl TJ, Allen SR. The papanicolaou smear: inadequate screening test for bacterial vaginosis during pregnancy. Am J Obstet Gynecol 2000;182:1048-1049.
65. Audisio T, Pigini T, de Riutort SV, et al. Validity of the Papa-nicolaou Smear in the Diagnosis of Candida spp., Trichomo-nas vaginalis, and bacterial vaginosis. J Low Genit Tract Dis 2001;5:223-225.
66. Heller DS, Pitsos M, Skurnick J. Does the presence of vag-initis on a Pap smear correlate with clinical symptoms in the patient? J Reprod Med 2008;53:429-434.
67. Biagi E, Vitali B, Pugliese C, et al. Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study. Eur J Clin Microbiol Infect Dis 2009;28:281-285.
68. Oakley BB, Fiedler TL, Marrazzo JM, et al. Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol 2008;74:4898-4909.
69. Srinivasan S, Fredricks DN. The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis 2008;750479, 2008.
70. De BE, Verhelst R, Verstraelen H, et al. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between Lactobacillus gasseri and Lactobacillus iners. BMC Microbiol 2007;7:115.
71. Kalra A, Palcu CT, Sobel JD, et al. Bacterial vaginosis: culture-and PCR-based characterizations of a complex polymicrobial disease's pathobiology. Curr Infect Dis Rep 2007;9:485-500.
72. Vitali B, Pugliese C, Biagi E, et al. Dynamics of vaginal bacterial communities in women developing bacterial vagi-nosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol 2007;73:5731-5741.
73. Verhelst R, Verstraelen H, Claeys G, et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopo-bium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 2004;4:16.
74. Bistoletti P, Fredricsson B, Hagstrom B, et al. Comparison of oral and vaginal metronidazole therapy for nonspecific bacterial vaginosis. Gynecol Obstet Invest 1986;21:144-149.
75. Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 2009:CD006055.
76. Cunningham FE, Kraus DM, Brubaker L, et al. Pharmacoki-netics of intravaginal metronidazole gel. J Clin Pharmacol 1994;34:1060-1065.
77. Schindler EM, Thamm H, Ansmann EB, et al. Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparison with metronidazole [in German]. Fortschr Med 1991;109:138-140.
78. Voorspoels J, Casteels M, Remon JP, et al. Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet. Eur J Obstet Gynecol Reprod Biol 2002;105:64-66.
79. Hanson JM, McGregor JA, Hillier SL, et al. Metronidazole for bacterial vaginosis: a comparison of vaginal gel vs. oral therapy. J Reprod Med 2000;45:889-896.
80. Brandt M, Abels C, May T, et al. Intravaginally applied met-ronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects. Eur J Obstet Gynecol Reprod Biol 2008;141:158-162.
81. Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 1992;79:1020-1023.
82. Andres FJ, Parker R, Hosein I, et al. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. South Med J 1992;85:1077-1080.
83. Fischbach F, Petersen EE, Weissenbacher ER, et al. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993; 82:405-410.
84. Paavonen J, Mangioni C, Martin MA, et al. Vaginal clindamy-cin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol 2000;96:256-260.
85. Ferris DG, Litaker MS, Woodward L, et al. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995;41:443-449.
86. Mikamo H, Kawazoe K, Izumi K, et al. Comparative study on vaginal or oral treatment of bacterial vaginosis. Chemotherapy 1997;43:60-68.
87. Schwebke JR, Desmond RA. A randomized trial of the duration of therapy with metronidazole plus or minus azithro-mycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 2007;44:213-219.
88. Livengood CH III, Ferris DG, Wiesenfeld HC, et al. Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol 2007;110(2 Pt 1):302-309.
89. Buranawarodomkul P, Chandeying V, Sutthijumtroon S. Seven Day Metronidazole versus single day tinidazole as therapy for non-specific vaginitis. J Med Assoc Thai 1990; 73:283-287.
90. Milani M, Barcellona E, Agnello A. Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vagi-nosis: a randomized, investigator-blinded, controlled trial. Eur J Obstet Gynecol Reprod Biol 2003;109:67-71.
91. Heikkinen J, Vuopala S. Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecol Obstet Invest 1989;28: 98-100.
92. Wang FM, Qian XD, Xu H, et al. Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis [in Chinese]. Zhonghua Yi Xue Za Zhi 2008;88:2201-2203.
93. Wathne B, Holst E, Hovelius B, et al. Erythromycin versus metronidazole in the treatment of bacterial vaginosis. Acta Obstet Gynecol Scand 1993;72:470-474.
94. Covino JM, Black JR, Cummings M, et al. Comparative evaluation of ofloxacin and metronidazole in the treatment of bacterial vaginosis. Sex Transm Dis 1993;20:262-264.
95. Wathne B, Hovelius B, Holst E. Cefadroxil as an alternative to metronidazole in the treatment of bacterial vaginosis. Scand J Infect Dis 1989;21:585-586.
96. Saracoglu F, Gol K, Sahin I, et al. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole. Int J Gynaecol Obstet 1998;62:59-61.
97. Nunez JT, Gomez G. Low-dose secnidazole in the treatment of bacterial vaginosis. Int J Gynaecol Obstet 2005;88:281-285.
98. Krulewitch CJ. An unexpected adverse drug effect. J Midwifery Womens Health 2003;48:67-68.
99. Caro-Paton T, Carvajal A, Martin de DI, et al. Is metronida-zole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997; 44:179-182.
100. Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998;105:322-327.
101. Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 2003;20:405-414.
102. Bar-Oz B, Bulkowstein M, Benyamini L, et al. Use of antibiotic and analgesic drugs during lactation. Drug Saf 2003;26: 925-935.
103. Rosen AD, Rosen T. Study of condom integrity after brief exposure to over-the-counter vaginal preparations. South Med J 1999;92:305-307.
104. Voeller B, Coulson AH, Bernstein GS, et al. Mineral oil lubricants cause rapid deterioration of latex condoms. Contraception 1989;39:95-102.
105. Trexler MF, Fraser TG, Jones MP. Fulminant pseudomem-branous colitis caused by clindamycin phosphate vaginal cream. Am J Gastroenterol 1997;92:2112-2113.
106. Hager WD, Rapp RP. Metronidazole. Obstet Gynecol Clin North Am 1992;19:497-510.
107. Austin MN, Beigi RH, Meyn LA, et al. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 2005;43:4492-4497.
108. Beigi RH, Austin MN, Meyn LA, et al. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004;191:1124-1129.
109. Bahar H, Torun MM, Ocer F, et al. Mobiluncus species in gynaecological and obstetric infections: antimicrobial resistance and prevalence in a Turkish population. Int J Antimi-crob Agents 2005;25:268-271.
110. Nagaraja P. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis. Indian J Med Microbiol 2008; 26:155-157.
111. Schwebke JR. Metronidazole: utilization in the obstetric and gynecologic patient. Sex Transm Dis 1995;22:370-376.
112. Simoes JA, Aroutcheva A, Heimler I, et al. Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility. Am J Obstet Gynecol 2001;185:1186-1190.
113. De BE, Verhelst R, Verstraelen H, et al. Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis 2006;6:51.
114. Chaithongwongwatthana S, Limpongsanurak S, Sitthi-Amorn C. Single hydrogen peroxide vaginal douching versus single-dose oral metronidazole for the treatment of bacterial vaginosis: a randomized controlled trial. J Med Assoc Thai 2003;86(suppl 2):S379-S384.
115. Hallen A, Jarstrand C, Pahlson C. Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 1992;19(3):146-148.
116. Neri A, Sabah G, Samra Z. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstet Gynecol Scand 1993; 72(1):17-19.
117. Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, Wilkinson FE, et al. Therapy of bacterial vaginosis using exog-enously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzne-imittelforschung 1996;46(1):68-73.
118. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Inges-tion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996;5(10):593-596.
119. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001;32(1):37-41.
120. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003;35(2):131-134.
121. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008;8:3.
122. Ozkinay E, Terek MC, Yayci M, et al. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG 2005;112:234-240.
123. Anukam K, Osazuwa E, Ahonkhai I, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lac-tobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 2006;8:1450-1454.
124. Anukam KC, Osazuwa E, Osemene GI. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metro-nidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006;8:2772-2776.
125. Donders GG, Pohlig G, Kaiser R, et al. Effect of lyophilised lactobacilli and 0.03 mg estriol (Gynoflor) on vaginitis and vaginosis with disrupted vaginal microflora A multi-centre, randomised, single-blind, active-controlled pilot study. Ob-stet Gynecol Invest In press.
126. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006;194:1283-1289.
127. Larsson PG, Stray-Pedersen B, Ryttig KR, et al. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008;8:3.
128. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478-1486.
129. Marcone V, Calzolari E, Bertini M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol 2008;31: 429-433.
130. Wilson JD, Shann SM, Brady SK, et al. Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment. Int J STD AIDS 2005;16:736-738.
131. Simoes JA, Bahamondes LG, Camargo RP, et al. A pilot clinical trial comparing an acid-buffering formulation (ACID-FORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol 2006;61: 211-217.
132. Banhidy F, Acs N, Puho EH, et al. Rate of preterm births in pregnant women with common lower genital tract infection: a population-based study based on the clinical practice. J Matern Fetal Neonatal Med 2009;22:410-418.
133. Lee SE, Romero R, Kim EC, et al. A high Nugent score but not a positive culture for genital mycoplasmas is a risk factor for spontaneous preterm birth. J Matern Fetal Neonatal Med 2009;22:212-217.
134. Donati L, Di VA, Nucci M, et al. Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet 2010;281:589-600.
135. Verstraelen H, Verhelst R, Claeys G, et al. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal micro-flora and that Lactobacillus gasseri and/or Lactobacillus iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol 2009;9:116.
136. Villar J, Gulmezoglu AM, de Onis M. Nutritional and antimicrobial interventions to prevent preterm birth: an overview of randomized controlled trials. Obstet Gynecol Surv 1998;53: 575-585.
137. Leitich H, Brunbauer M, Bodner-Adler B, et al. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 2003;188:752-758.
138. McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2005:CD000262.
139. Nygren P, Fu R, Freeman M, et al. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the US Preventive Services Task Force. Ann Intern Med 2008;148:220-233.
140. Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005;105:857-868.
141. Riggs MA, Klebanoff MA. Treatment of vaginal infections to prevent preterm birth: a meta-analysis. Clin Obstet Gynecol 2004;47:796-807.
142. Simcox R, Sin WT, Seed PT, et al. Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis. Aust N Z J Obstet Gynaecol 2007;47:368-377.
143. Varma R, Gupta JK. Antibiotic treatment of bacterial vagino-sis in pregnancy: multiple meta-analyses and dilemmas in interpretation. Eur J Obstet Gynecol Reprod Biol 2006;124: 10-14.
144. Guise JM, Mahon SM, Aickin M, et al. Screening for bacterial vaginosis in pregnancy. Am J Prev Med 2001;20(suppl 3): 62-72.
145. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007:CD000262.
146. Morency AM, Bujold E. The effect of second-trimester antibiotic therapy on the rate of preterm birth. J Obstet Gynaecol Can 2007;29:35-44.
147. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534-540.
148. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metro-nidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-493.
149. Odendaal HJ, Popov I, Schoeman J, et al. Preterm labour-is bacterial vaginosis involved? S Afr Med J 2002;92:231-234.
150. Kurkinen-Raty M, Vuopala S, Koskela M, et al. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 2000;107:1427-1432.
151. Guaschino S, Ricci E, Franchi M, et al. Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial. Eur J Obstet Gynecol Reprod Biol 2003; 110:149-152.
152. Joesoef MR, Hillier SL, Wiknjosastro G, et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on pre-term delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527-1531.
153. Kekki M, Kurki T, Pelkonen J, et al. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001;97(5 Pt 1):643-648.
154. Lamont RF, Jones BM, Mandal D, et al. The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Infect Dis Obstet Gynecol 2003;11: 181-189.
155. Larsson PG, Fahraeus L, Carlsson B, et al. Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG 2006;113:629-637.
156. Ugwumadu A, Manyonda I, Reid F, et al. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003; 361:983-988.
157. Holst E, Brandberg A. Treatment of bacterial vaginosis in pregnancy with a lactate gel. Scand J Infect Dis 1990;22: 625-626.
158. Othman M, Neilson JP, Alfirevic Z. Probiotics for preventing preterm labour. Cochrane Database Syst Rev 2007: CD005941.
159. Colli E, Landoni M, Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med 1997;73:267-270.
160. Siboulet A. Vaccination against nonspecific bacterial vagino-sis. Double-blind study of Gynatren [in German]. Gynakol Rundsch 1991;31:153-160.
161. Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005; 106(5 Pt 1):1013-1023.
162. Swidsinski A, Mendling W, Loening-Baucke V, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 2008;198:97-196
163. Ferris MJ, Masztal A, Aldridge KE, et al. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 2004;4:5.
164. Gupta JK, Williams C. Evidence for preventing infection in abortion care. Eur J Contracept Reprod Health Care 2007; 12:191-193.
165. Hay PE. Bacterial vaginosis and miscarriage. Curr Opin Infect Dis 2004;17:41-44.
166. Ou MC, Pang CC, Chen FM, et al. Antibiotic treatment for threatened abortion during the early first trimester in women with previous spontaneous abortion. Acta Obstet Gynecol Scand 2001;80:753-756.
167. Miller L, Thomas K, Hughes JP, et al. Randomised treatment trial of bacterial vaginosis to prevent post-abortion complication. BJOG 2004;111:982-988.